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Abstract  
Objective:   To determine the outcome after using long coronary stents >20 mm for long 
coronary lesions among patients treated at Queen Alia Heart Institute.  
Methods:    This  is  a  descriptive,  and  a  retrospective  non  randomized  study  which  was 
conducted  at  Queen  Alia  Heart  Institute  on  900  adult  patients  who  underwent  coronary 
angiography and intervention for either stable or unstable angina pectoris during the period 
between 2006 to 2011. Those patients had coronary intervention using a single long stent for 
each long lesion (>20 mm). Their follow up was analyzed and the outcome of these long 
stents was studied for in stent restenosis or in stent total occlusion in each specific coronary 
artery.  A  specially  designed  form  was  used  to  record  the  following  data  in  the  involved 
patients:  age,  gender,  size  and  type  of  coronary  stent  (drug  eluting  or  bare  metal),  the 
presence of diabetes mellitus, hypertension or hypercholesterolemia, and the status of the left 
ventricle. 
Results:  The total number of patients who had long coronary stent intervention was 900 
cases. Four hundred eighty patients (53.3%) had restudy cardiac catheterization within 6-8 
months,  which  showed  instent  restenosis  or  instent  total  occlusion  in  90  patients.  Males 
constituted  the  majority  (88.9%)  of  the  affected  patients.  Smoking  was  the  commonest 
(83.3%)  factor  associated  with  instent  restenosis  followed  by  Diabetes  Mellitus  (61.1%). 
About half the cases of long instent restenosis was found in left anterior descending artery, 
whereas  right  coronary  artery  and  circumflex  artery  had  almost  equal  ratios:  23.3%  and 
22.2% respectively. Long instent restenosis was commoner (33.3%) in ostial lesions and was 
the least (14.5%) in mid segment lesions. Bare metal stents were associated with the majority 
(77.8%) of cases of instent restenosis. About two thirds of the affected patients had small 
caliber stents (2.5 and 2.75 mm diameter).  
Conclusion:  Instent restenosis or instent total occlusion in long coronary stents is a well 
recognized and not uncommon clinical entity. Men are more commonly affected than women. 
Ostial  left  anterior  descending  artery  is  more  affected  than  other  coronaries.  Smoking, 
Diabetes Mellitus and the use of bare metal stents of small sized caliber (≤ 2.75 mm) were Marwan Adib Al-Nimri  
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common  in  our  study  patient  population  and  associated  with  increased  incidence  of  long 
instent restenosis. 
Keywords:  long coronary lesions; Instent restenosis  
Introduction: 
Stent  implantation  has  significantly 
reduced  the  short  and  long  term 
complications  in  patients  undergoing 
percutaneous  coronary  intervention 
compared with angioplasty alone.
( 
Fischman  et 
al., 1994) 
Many studies that evaluated the  outcome 
of treating patients with coronary stents 
 have  identified  a  series  of  risk  factors 
associated  with  restenosis.  One  of  which 
was the length of the diseased segment of 
the  coronary  artery  and  subsequently  the 
lengthof  the  stent  used  to  treat  that 
lesion.
(Bauters et al., 1998 & Mercado et al., 2001& Hausleiter 
et al 2002)  
In fact, the lesion length was considered as 
an  independent  factor  for  early 
complications  and  late  restenosis 
following  balloon  angioplasty.
( 
Rensing  et  al., 
1993 & Hermans  et al., 1993) 
Although  the  introduction  of  coronary 
stents  has  resulted  in  a  considerable 
reduction in restenosis rate of long lesions, 
it  is  still  relatively  significant  and  the 
stented segment length is an independent 
predictor of instent restenosis.
( 
Lee  et al.,2001) 
However, Drug eluting stent implantation 
has  been  proved  to  markedly  reduce  the 
incidence of restenosis across a wide range 
of coronary lesions.
( 
Lemos et al., 2004 &  Ong et al., 
2005)  ,  In  this  report,  we  investigate  the 
clinical  and  angiographic  outcome  of 
single long  
coronary  stenting  for  long  lesions  in  a 
consecutive  group  of  480  patients  who 
were treated with at least 20 mm of stent 
length.  
Methods: 
   This is a descriptive and a retrospective 
non- randomized study which was  
conducted at Queen Alia Heart Institute in 
Amman – Jordan, during January 2006 to  
January 2011, on 900 adult patients (>18 
years) who underwent coronary  
angiography  and  intervention  during  that 
period because of either stable or unstable  
angina. 
 The  involved  patients  had  coronary 
intervention for long lesions requiring long 
stents  >  20  mm.  Restudy  cardiac 
catheterization was done for 480 patients 
who  had  recurrence  of  angina,  new 
electrocardiographic  ischemic  changes  or 
positive treadmill stress test on follow up 
clinic  visit  within  6-8  months  since  the 
original coronary intervention. 
 Their follow up at clinic was analyzed and 
the  angiographic  outcome  of  these  long 
stents was studied for instent restenosis or 
instent  total  occlusion  in  each  specific 
coronary artery considering the site of the 
lesion, and the size and type of coronary 
stent  used  (drug  eluting  or  bare  metal). 
Instent  restenosis  was  considered  present 
if it exceeded 50% stenosis. Long Coronary Lesions Requiring Long Stents…  
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 A  specially  designed  form  was  used  to 
collect the following relevant data for the 
involved  patients:  age,  gender,  smoking, 
the  presence  of  diabetes  mellitus, 
hypertension or hypercholesterolemia, and 
the status of the left ventricle.  
Left ventricular function was assessed by 
2-D echocardiography. 
Results:  
     The age of the study patient population 
ranges from 40 to 79 years.  
Table  I  presents  the  frequency  of  long 
stents  instent  restenosis  or  instent 
occlusion  among  the  study  group  which 
was 90 patients (18.8%). Males were the 
majority  (88.9%)  of  patients  with  long 
instent restenosis. 
Table II shows the distribution of cases of 
long stents instent restenosis according to 
 different  age  groups.  The  commonest 
(33.8%) in males was the age group 40-49 
 years,  and  the  commonest  (70.0%)  in 
females was the age group 70-79 years.  
Long  instent  restenosis  was  not  seen  in 
women below the age of 60 years. 
 Table  III  demonstrated  the  possible 
factors  associated  with  increased  risk  of 
instent  restenosis,  smoking  was  the 
commonest (83.3%) followed by Diabetes 
Mellitus  in  61.1%  of  cases,  whereas 
hypercholesterolemia  being  the  lowest 
(11.1%).  Almost half the cases of instent 
restenosis occurred in patients with normal 
left ventricle on 2-D echocardiography and 
the second half occurred  in patients with 
left ventricular impairment. 
 As  illustrated  in  table  IV,  left  anterior 
descending coronary was the commonest 
 (54.5%)  affected  artery,  while  right 
coronary  and  circumflex  arteries  had 
almost  equal  ratios;  about  a  quarter  for 
each,  with  the  ostial  segment  being  the 
commonest  (33.3%)  part  of  the  coronary 
arteries  to  be  involved  in  long  instent 
restenosis  followed  by  the  proximal 
segment  (28.9%)  while  the  mid  segment 
was the least (14.5%) to be affected, as can 
be seen in table V. 
As can be observed in table VI, long stents 
restenosis was commoner (77.8%) with 
 bare metal stents and the majority of them 
were small caliber (≤ 2.75 mm), as table 
 VII demonstrates.  
Discussion: 
      Since  the  mid  nineties,  particularly 
after the provision of a new generation of 
stents,  the  intervention  treatment  of  long 
coronary  lesions  has  become  routinely 
adopted, as the in hospital and late results 
are almost similar to those reported in the 
treatment  of  focal  lesions.
(Freed  et  al.,  1996  & 
Ruygrok  et  al.,  1996)  The  frequency  of  long 
instent restenosis in our study was 18.8%. 
This tendency is lower than the ratio found 
in other reports
 (Kim et al., 2006 & Kim et al., 2001 & 
Kim  et  al.,  1998  &  Foley  et  al.,  2001)    of  patients 
referred  for  coronary  angiography  with 
subsequent  long  stents  implantation. 
Nevertheless,  other  studies
  (Kim  et  al.,  2006) 
reported  even  a  lower  rate  of  instent 
restenosis than  what was obtained in our 
trail.  This  variable  frequency  of  long 
instent  restenosis  in  the  literature  can  be Marwan Adib Al-Nimri  
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explained  partly  by  the  difference  in  the 
lesions  length  considered  in  the  different 
studies, and the variety of stent types and 
designs  employed  by  these  studies. 
Besides,  there  should  be  essential 
variations  between  patients  clinical 
baseline  and  angiographic  and  lesions 
characteristics, in addition to the dissimilar 
deployment techniques and antithrombotic 
therapy protocols. 
We  believe,  the  real  frequency  of  long 
instent restenosis could be higher than the 
ratio obtained in this study, because only 
53.3%  of  patients  who  had  long  stents 
intervention  were  subjected  to  restudy 
cardiac  catheterization  due  to  their 
symptoms,  while  the  remainders 
asymptomatic  patients  were  not  studied 
although  they  could  have  silent  instent 
restenosis.  One  another  relevant  point  is 
the restudy timing of the involved patients 
was  relatively  short  (6–8  months),  if  the 
period was extended, for example, to one 
year the rate of instent restenosis would be 
higher. Long instent restenosis appears to 
be more common in males than in females 
in  our  study  which  is  similar  to  other 
reports
 (Samad et al., 2011 & Luiz et al., 1999) with the 
commonest age  group 40–49 years to be 
affected.  This  may  reflect  the  selectivity 
and  prejudice  of  female  referrals  for 
cardiac  catheterization  and  angiography 
with coronary intervention. 
The most frequent risk factors in our study 
associated  with  long  instent  restenosis 
were smoking and diabetes mellitus. This 
was consistent with what was reported in 
the literature.
( Luiz et al., 1999 & Gaku et al., 2006 & Lee 
et al., 2006  & Hoffmann et al., 2000)  
Hypertension  and  hypercholesterolemia 
were also involved, but to a lesser extent. 
All  these  factors  can  be  expected  to  be 
associated  with  instent  restenosis  as they 
are already part of the risk factors group 
for coronary artery atherosclerosis.            
This study showed a higher prevalence of 
the  left  anterior  descending  coronary 
artery to be involved in instent restenosis 
especially  in  the  ostial  and  proximal 
segments. 
 A  finding  that  agreed  with  what  was 
reported in other studies. 
(Kim et al., 1998 & Foley 
et  al.,  1994  &  Kuntz  et  al.,  1992)  This  raised  the 
question  of  considering  left  anterior 
descending artery itself as an independent 
predictor  of  restenosis  after  long  stent 
implantation.  Similar  to  the  findings  in 
other reports,
( Kim et al., 2006 & Samad et al., 2011 & 
Dawkins et al.,  2005 & Kim et al., 2011) most cases of 
restenosis in this study occurred in patients 
with bare metal stents of small diameter (≤ 
2.75 mm), while drug eluting stents have 
been shown to reduce restenosis across a 
wide  spectrum  of  stents  lengths  and 
diameters.  So  a  lower  ratio  of  restenosis 
could  be  achieved,  as  bare  metal  stents 
constituted the  majority  of stents used  in 
our study because of some logistic issues 
we  used  different  types  of  bare  or  drug 
eluting  stents  depending  on  their 
availability once the procedure performed.   
 Our  study  did  not  examine  the  outcome 
beyond  eight  months,  whereas  longer–
term  assessment  may  provide  useful Long Coronary Lesions Requiring Long Stents…  
352  
 
knowledge  regarding  the  occurrence  of 
late restenosis after drug eluting coronary 
stent implantation.  
Finally,  Stent  implantation  for  long 
coronary  lesions  is  associated  with 
excellent  procedural  success  rates  in  the 
majority of cases. However the restenosis 
rate  is  relatively  high,  since  multiple 
factors  including  vessel  diameter,  lesion 
location, anginal status, diabetic status and 
extent  of  vessel  disease  also  play 
important determining roles. 
Table I: Frequency of long stents ISR and according to gender 
Total no. of pts 
who had long 
coronary stents 
No. of symptomatic pts 
who had restudy cath (%) 
No. of patients with long stent 
ISR (%) 
Male (%)  Female 
(%)  
900(100%)  480(53.3%)  90(18.8%)  80(16.7%)  10(2.1
%) 
%    100%  88.9%  11.1% 
ISR: in stent restenosis 
 
Table II:  Distribution of patients with long stents ISR or stent occlusion according to 
different age groups and gender 
Age group (years)  No. of males (%)  No. of females (%)   Total (%) 
40 – 49  27 (33.8%)  0 (0.0%)  27 (30.0%) 
50 – 59  22 (27.5%)  0 (0.0%)  22 (24.4%) 
60 – 69   14 (17.5%)  3 (30.0%)  17 (18.9%) 
70 – 79  17 (21.2%)  7 (70.0%)  24 (26.7%) 
Total  80 (100%)  10 (100%)  90 (100%) 
ISR: in stent restenosis 
 
Table III:  General analysis of patients with long stents ISR or stent occlusion in respect 
to certain risk factors 
Total   90 patients  No. of patients  % 
Smokers  75  83.3%  
Presence of Diabetes Mellitus  55  61.1% 
Presence of hypertension  20  22.2% 
Presence of hypercholesterolemia   10  11.1% 
Left ventricle normal function  44  48.9% 
Presence of left ventricular impairment  46  51.1% 
ISR: in stent restenosis 
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Table IV:  Frequency of long stents ISR or stent occlusion according to the involved 
coronary artery 
  RCA   LAD   Cx.   Total 
No.  21  49  20  90 
%  23.3%  54.5%  22.2%  100% 
 ISR: in stent restenosis                              RCA: right coronary artery. 
LAD: left anterior descending artery.          Cx: circumflex artery. 
 
Table V: Frequency of long stents ISR or stent occlusion according to the anatomical 
site in the involved coronary arteries 
Ostial  Proximal segment  Mid segment  Distal segment  Total 
30  26  13  21  90 
33.3%  28.9%  14.5%  23.3%  100% 
ISR: in stent restenosis 
 
 
Table VI: Frequency of long stents ISR or stent occlusion according to the type of the 
stent 
  Drug Eluting Stent 
(DES) 
Bare Metal Stent 
(BMS) 
Total 
No. of patients  20  70  90 
%  22.2%  77.8%  100% 
ISR: in stent restenosis 
 
 
 
Table VII:  Frequency of long stents ISR or stent occlusion according to the size of the 
stent used (diameter of the stent in mm) 
Size of the stent (caliber in mm)  No. of patients  % 
2.5 mm  32  35.6%  
2.75 mm   29  32.2% 
3.0 mm  21  23.3% 
3.5 mm   8  8.9% 
Total  90  100.0% 
ISR: in stent restenosis   Long Coronary Lesions Requiring Long Stents…  
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 ةليوطلا ةمعادلا تاكبشلا مادختسا جئاتن ليلحت (  نم رثكا 02   ملم  )  يف  ةيليلكلإا نييارشلا يف
 بلقلا ةحارجو ضارملا ءايلع ةكلملا زكرم يف بلقلا ىضرم جلاع –   ندرلاا  
د  .  بلقلا ةحارجو ضارملا ءايلع ةكلملا زكرم يرمنلا بيدا ناورم –   ندرلاا  
 ةصلاخ :  
  فدهلا :    ةليوطلا ةمعادلا تاكبشلا مادختسا مييقتو ةجيتن ةفرعم (  نم رثكا 02   ملم  )  تاذ ةيليلكلإا نييارشلا جلاع يف
 بلقلا ةحارجو ضارملا ءايلع ةكلملا زكرم يف نوجلاعي نيذلا ىضرملا ىدل  ةليوطلا تاقيضتلا –   ندرلاا .  
 
لئاسولا :      ىلع ةساردلا تيرجا 022   خ ضيرم  ةليوطلا ةمعادلا تاكبشلا ةطساوب لخادتلاو ةيليلكلإا ةرطسقلل اوعض
ةيردصلا ةحبذلا ببسب    نيب ةرتفلا للاخ 0222   –   0222  .  مت  دعب ىضرملا ةعباتم 2   -   8    تاقيضت ثودح ةبسن ةفرعمل رهشأ
كلذ لوصح ىلع ةدعاسملا لماوعلا كلذكو ةليوطلا ةمعادلا تاكبشلا يف  .  اجذومن اذهل ممص دقو ةيلاتلا تانايبلا ليجستل  :
نسلاو سنجلا  , ةمدختسملا ةمعادلا ةكبشلا رطقو لوطو عون  , مدلا طغض عافتراو يركسلا ضرم دوجو  , وأ   لورتسيلوكلا  ,
بلقلا ةلضع ةلاح كلذكو .  
 
جئاتنلا :    يف ةليوطلا ةمعادلا تاكبشلا يف تاقيضت ثودح رهظ 02    ةرطسقلا ةداعا مت يتلا تلااحلا عومجم نم ضيرم
لا اهل ةيبلق  .  ةيبلاغلا روكذلا لكشيو ( 88.0  )% ىضرملا نم  .  يه تاقيضتلا كلت ثودحب ةطبترملا لماوعلا رثكا تناك
 نيخدتلا ( 88.8  )% يركسلا هيلي (61.1%)   . ناك    تاكبشلا يف تاقيضت ثودحب ارثات رثكلاا طباهلا رسيلاا يليلكلإا نايرشلا
  يلولاا ءزجلا يف اصوصخ ةليوطلا ةمعادلا ( 88.8    (%    , ةباصا لقلاا ءزجلا ناك نايرشلا فصتنم امنيب  .  تثدح ...8  %
ةيلطملا ريغ ةيندعملا ةمعادلا تاكبشلا يف قيضتلا تلااح نم .      مهجلاع مت دق ناك  نيباصملا ىضرملا يثلث يلاوح
رطقلا ةريغص تاكبش مادختساب 0.2      و 0..2 ملم   .  
 
ةصلاخ :    لا ةيليلكلاا تاكبشلا يف تاقيضت ثودح ربتعي ةردانلا ريغو ةفورعملا ةيبطلا تافعاضملا  نم ةليوطلا ةمعاد  .
يركسلا ءاد نم نوناعي نيذلاو نينخدملا اصوصخ ةارملا نم اررضت رثكأ مه لاجرلا  .  ةمعادلا تاكبشلا مادختسا نا
 نم لقا مجحلا ةريغص ةيلطملا ريغ ةيندعملا ةليوطلا 0..2    صوصخ طباهلا رسيلاا يليلكلإا نايرشلا يف ملم  ءزجلا يف ا
هنم  يلولاا  , تاكبشلا كلت لخاد تاقيضت ثودحب ةطبترملا  لماوعلا مها نم ربتعي .  
 
ةيسيئر تاملك :   ةليوط ةيليلكإ تاقيضت  , معادلا تاكبشلا يف تاقيضت ة  